COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR

Video Credit: ANI
Published on August 4, 2020 - Duration: 02:24s

COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR

Director General of Indian Council of Medical Research, Dr Balram Bhargava on August 04 stated that Oxford vaccine, being manufactured by Serum Institute of India, got approval for phase 2 and 3 clinical trials which are starting within a week at 17 sites.

Earlier, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India (SII), Pune, to conduct Phase II and III clinical trials of Oxford vaccine.


You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions



Serum Institute of India

Indian biotechnological company, vaccine manufacturer
Gandhi's tweet came after Prime Minister Narendra Modi aired his monthly 'Mann ki baat' programme on the All India Radio (AIR). Along with his comment, Gandhi..
Credit: IndiaTimes - Published 7 hours ago

It is to be noted that the Serum Institute of India is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford..
Credit: DNA - Published 8 hours ago

On September 16, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India (SII) to restart its phase two and three clinical trials for..
Credit: DNA - Published 1 day ago

The phase-III human clinical trial of the Covid-19 vaccine being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began at..
Credit: IndiaTimes - Published 6 days ago


The ICMR's second sero-survey shows that Indian population is still far from achieving herd immunity against coronavirus infection, Union health minister Harsh..
Credit: IndiaTimes - Published 9 hours ago

ICMR said it has communicated to states the findings of a serosurvey in "dynamic containment zones" in 10 cities, which "do not fit into the..
Credit: IndiaTimes - Published 1 week ago


Pune

Place in Maharashtra, India
The missile has been developed by Armament Research & Development Establishment (ARDE) Pune in association with High Energy Materials Research Laboratory (HEMRL)..
Credit: DNA - Published 4 days ago


Related videos from verified sources

Record 12 lakh COVID tests conducted across India in last 24 hours 01:26
Video credit: ANI - Published 1 week ago 

If all goes well, expect COVID vaccine by early next year: AIIMS doctor 02:26
Video credit: ANI - Published 1 week ago 

India's COVID recoveries cross 41 lakh mark, active infections past 10 lakh 01:38
Video credit: ANI - Published 1 week ago 

You might like